Relating to prescription drug costs.
Do you support it?
Want to know if it passes?
We'll email you when SB 399 moves — a committee vote, a floor vote, or a signature. Nothing else.
Free forever · unsubscribe in one click.
Your answer was recorded either way.
Which district are you in?
Your ZIP is all we need to match you to your own representatives — so we can tell you how they voted on SB 399.
You're tracking SB 399
We'll email you the moment it moves.
SB 399 — Relating to prescription drug costs.
Last action — In committee upon adjournment.
No card. One bill, free forever — alerts when it moves.
-
✓Introduced
-
2In Committee
-
3Passed Senate
-
4Passed House
-
5To Executive
-
6Enacted
This bill died with 2017 Regular Session. It reached “In Committee” and never advanced before the session ended, so it can no longer move — a new version would have to be reintroduced in the current session.
This bill is no longer active — its legislative session has ended, so there is no live prognosis. It would have to be reintroduced in the current session to move again.
Summary
Prohibits small employer, group or individual health benefit plan from requiring enrollee in plan to incur more than $250 in out-of-pocket costs for covered prescription drugs purchased during single retail encounter. Requires prescription drug manufacturer to have process for providing rebate to insurer of difference between $250 and copayment for prescription drug under express terms of health benefit plan. Becomes operative January 1, 2019.
Bill Text
We don't have the full text on file for this bill yet.
Read SB 399 on the official Oregon source →Action History
-
In committee upon adjournment.
-
Referred to Health Care.
-
Introduction and first reading. Referred to President's desk.
Sponsors
- Elizabeth Steiner Hayward · Primary
Sponsorship breakdown
Export CSV (upgrade) →1 sponsors · 0 co-sponsors · 89 not signed on
Sponsors (1)
Co-sponsors (0)
None.
Not signed on (89)
89 members have not signed on to this bill.
Show all 89 →"Not signed on" means a member has not sponsored or co-sponsored this bill — it does not imply opposition. Members flagged Voted No have a recorded No vote on this bill.
Subjects
Frequently asked questions
- What does SB 399 do?
- Prohibits small employer, group or individual health benefit plan from requiring enrollee in plan to incur more than $250 in out-of-pocket costs for covered prescription drugs purchased during single retail encounter. Requires prescription drug manufacturer to have process for providing rebate to insurer of difference between $250 and copayment for prescription drug under express terms of health benefit plan. Becomes operative January 1, 2019.
- Who sponsors SB 399?
- SB 399 is sponsored by Elizabeth Steiner Hayward.
- What is the current status of SB 399?
- This bill died with 2017 Regular Session. It reached “In Committee” and never advanced before the session ended, so it can no longer move — a new version would have to be reintroduced in the current session.
- Where can I track SB 399?
- Track SB 399 free on One Click Politics — get push/email alerts when it moves.
Make your voice heard on SB 399
Find the representatives who decide this bill and tell them where you stand — for yourself, or mobilize your whole list in one click with One Click Politics advocacy software.
Stay ahead of SB 399
Last checked for changes 3 months ago · updated continuously
One Click Politics tracks every bill in Congress and all 50 states.
Track this bill →